Food and Drug Administration
-
Three Philadelphia Scientists Win 2026 Breakthrough Prize for FDA-Approved Gene Therapy Development
Three Philadelphia scientists were recently named the winners of the 2026 Breakthrough Prize for their work in developing the first FDA-approved gene therapy for a…
-
With FDA Decision Looming, Plymouth Meeting’s Inovio Cuts Workforce to Preserve Cash
Over the past year, Plymouth Meeting-based Inovio Pharmaceuticals has reduced its workforce by 16 percent to preserve cash as it waits for the Food and…
-
Are Artificial Sweeteners Safe for Kids? What Parents Should Know
The American Academy of Pediatrics recommends kids ages two to 18 consume about six teaspoons of sugar per day. According to most sources, kids in…
-
Conshohocken’s ActiveProtective Launches Tango Belt, Eyes Nationwide Expansion
Conshohocken-based ActiveProtective has launched the Tango Belt, a fall prevention device that has been approved by the Food and Drug Administration, writes John George for…
-
Personal Tragedy Led Exton’s Kensey Nash Founder to New Role as Lungpacer Medical CEO
Personal tragedy led Doug Evans, founder of Exton-based Kensey Nash, to change his business trajectory and become CEO of Vancouver-based Lungpacer Medical, writes Brian Gormley…
-
Malvern Medical Manufacturer Cleared for First-of-Its-Kind Alzheimer’s Blood Test
A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has received clearance from the U.S. Food and Drug Administration, writes…
-
To Prep for First Product Launch, Exton’s Lungpacer Medical Doubles Workforce
Lungpacer Medical, headquartered in Canada with main operations in Exton, is raising funds and nearly doubling its workforce to support the commercial launch of its…
-
NRx in Radnor Asks Again for Approval to Use Its COVID-19 Drug, Zyesami
NRx Pharmaceuticals out of Radnor has once again filed an application with the Food and Drug Administration for emergency use of its experimental COVID-19 drug…
-
Promising Results From COVID Drug Pushes Up Radnor Pharm’s Stock
Patients treated with an NRx Pharmaceuitcals drug candidate targeting COVID-19 showed “substantial improvement,” an analysis shows. The news caused the Radnor company’s stock to…
-
Providing Non-Opioid Pain Relief, Newtown Square’s Innocoll Sees Surge in Share Price
The recent announcement of positive trial results for its new pain relief treatment sparked a surge in the share price of Newtown Square’s specialty pharmaceutical…
-
Irish Drug Company Appoints President of U.S. Operations in Radnor
Adapt Pharma, the Dublin, Ireland-based drug company, has appointed Mike Kelly as president of U.S. operations, located in Radnor, writes John George of the Philadelphia…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
